Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · IEX Real-Time Price · USD
4.690
+0.010 (0.21%)
At close: Jul 19, 2024, 4:00 PM
4.610
-0.080 (-1.71%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CAPR stock have an average target of 21.75, with a low estimate of 8.00 and a high estimate of 40. The average target predicts an increase of 363.75% from the current stock price of 4.69.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CAPR stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +752.88% | Jul 2, 2024 |
Oppenheimer | Oppenheimer | Buy Initiates $14 | Buy | Initiates | $14 | +198.51% | May 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +752.88% | May 14, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | +70.58% | May 14, 2024 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $24 → $25 | Strong Buy | Maintains | $24 → $25 | +433.05% | May 14, 2024 |
Financial Forecast
Revenue This Year
22.69M
from 25.18M
Decreased by -9.89%
Revenue Next Year
61.84M
from 22.69M
Increased by 172.56%
EPS This Year
-1.20
from -0.83
EPS Next Year
-0.90
from -1.20
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 42.0M | 194.3M | 154.0M | 205.7M | 355.4M |
Avg | 22.7M | 61.8M | 77.4M | 115.6M | 176.3M |
Low | 4.8M | n/a | 36.1M | 14.0M | 30.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 66.8% | 756.2% | 149.0% | 165.8% | 207.5% |
Avg | -9.9% | 172.6% | 25.1% | 49.3% | 52.6% |
Low | -80.9% | - | -41.7% | -81.9% | -73.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.65 | 1.34 | 0.61 | 1.14 | -0.86 |
Avg | -1.20 | -0.90 | -0.29 | -0.01 | -0.84 |
Low | -1.71 | -1.91 | -1.12 | -1.08 | -0.80 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.